UnitedHealth Group Incorporated $UNH Shares Sold by Calamos Advisors LLC

Calamos Advisors LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 30.3% in the 3rd quarter, HoldingsChannel reports. The fund owned 246,883 shares of the healthcare conglomerate’s stock after selling 107,512 shares during the quarter. Calamos Advisors LLC’s holdings in UnitedHealth Group were worth $85,249,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the business. Sax Wealth Advisors LLC raised its holdings in UnitedHealth Group by 23.8% in the 3rd quarter. Sax Wealth Advisors LLC now owns 874 shares of the healthcare conglomerate’s stock valued at $302,000 after buying an additional 168 shares during the period. Smith Salley Wealth Management increased its position in shares of UnitedHealth Group by 89.5% during the third quarter. Smith Salley Wealth Management now owns 12,873 shares of the healthcare conglomerate’s stock valued at $4,445,000 after acquiring an additional 6,079 shares during the last quarter. Generate Investment Management Ltd lifted its holdings in shares of UnitedHealth Group by 5.5% in the 3rd quarter. Generate Investment Management Ltd now owns 142,486 shares of the healthcare conglomerate’s stock worth $49,200,000 after acquiring an additional 7,486 shares during the last quarter. Lewis Asset Management LLC increased its holdings in UnitedHealth Group by 99.3% in the 3rd quarter. Lewis Asset Management LLC now owns 4,105 shares of the healthcare conglomerate’s stock valued at $1,417,000 after purchasing an additional 2,045 shares during the last quarter. Finally, Forefront Wealth Partners LLC lifted its stake in UnitedHealth Group by 107.0% during the third quarter. Forefront Wealth Partners LLC now owns 2,306 shares of the healthcare conglomerate’s stock worth $796,000 after purchasing an additional 1,192 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts recently issued reports on UNH shares. UBS Group increased their target price on UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. Leerink Partners set a $410.00 price objective on shares of UnitedHealth Group and gave the company an “outperform” rating in a report on Wednesday, October 29th. Deutsche Bank Aktiengesellschaft cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target for the company. in a research report on Wednesday, October 29th. Sanford C. Bernstein increased their price objective on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Finally, Barclays boosted their target price on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Seventeen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Hold” and a consensus price target of $385.54.

UnitedHealth Group Trading Up 1.0%

UNH opened at $332.13 on Wednesday. The business’s 50-day simple moving average is $332.33 and its 200-day simple moving average is $319.37. The company has a market cap of $300.86 billion, a P/E ratio of 17.33, a PEG ratio of 2.14 and a beta of 0.43. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $606.36. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter last year, the company earned $7.15 earnings per share. The firm’s revenue for the quarter was up 12.2% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date was Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.